Clinical Trial Update: Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a Factor XI inhibitor to prevent venous thromboembolism in patients undergoing total knee arthroplasty; the trial is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Factor XI inhibitor (Factor XI inhibitor)

Snippet

Sponsor: Suzhou Alphamab Co., Ltd. | Conditions: Knee Arthroplasty, Total | Phase 2 | Status: ACTIVE_NOT_RECRUITING